Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recommendations on screening for lung cancer.

Literature DB >> 26952527

Recommendations on screening for lung cancer.

Abstract

Entities: Disease

Mesh：

Year: 2016 PMID： 26952527 PMCID： PMC4818132 DOI： 10.1503/cmaj.151421

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

16 in total

1. Conceptualizing overdiagnosis in cancer screening.

Authors: Pamela M Marcus; Philip C Prorok; Anthony B Miller; Emily J DeVoto; Barnett S Kramer
Journal: J Natl Cancer Inst Date: 2015-02-06 Impact factor: 13.506

2. Introduction: Diagnosis and management of lung cancer: ACCP evidence-based clinical practice guidelines (2nd Edition).

Authors: W Michael Alberts
Journal: Chest Date: 2007-09 Impact factor: 9.410

3. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada.

Authors: Fiona M Clement; Anthony Harris; Jing Jing Li; Karen Yong; Karen M Lee; Braden J Manns
Journal: JAMA Date: 2009-10-07 Impact factor: 56.272

4. Cost-effectiveness of CT screening in the National Lung Screening Trial.

Authors: William C Black; Emmett B Keeler; Samir S Soneji
Journal: N Engl J Med Date: 2015-01-22 Impact factor: 91.245

5. Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization.

Authors: N Becker; E Motsch; M-L Gross; A Eigentopf; C P Heussel; H Dienemann; P A Schnabel; M Eichinger; D-E Optazaite; M Puderbach; M Wielpütz; H-U Kauczor; J Tremper; S Delorme
Journal: J Thorac Oncol Date: 2015-06 Impact factor: 15.609

Review 6. Screening for lung cancer.

Authors: Renée Manser; Anne Lethaby; Louis B Irving; Christine Stone; Graham Byrnes; Michael J Abramson; Don Campbell
Journal: Cochrane Database Syst Rev Date: 2013-06-21

7. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).

Authors: Carola A van Iersel; Harry J de Koning; Gerrit Draisma; Willem P T M Mali; Ernst Th Scholten; Kristiaan Nackaerts; Mathias Prokop; J Dik F Habbema; Mathijs Oudkerk; Rob J van Klaveren
Journal: Int J Cancer Date: 2007-02-15 Impact factor: 7.396

8. Cost-effectiveness of Lung Cancer Screening in Canada.

Authors: John R Goffin; William M Flanagan; Anthony B Miller; Natalie R Fitzgerald; Saima Memon; Michael C Wolfson; William K Evans
Journal: JAMA Oncol Date: 2015-09 Impact factor: 31.777

9. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

Authors: Andrea Lopes Pegna; Giulia Picozzi; Mario Mascalchi; Francesca Maria Carozzi; Laura Carrozzi; Camilla Comin; Cheti Spinelli; Fabio Falaschi; Michela Grazzini; Florio Innocenti; Cristina Ronchi; Eugenio Paci
Journal: Lung Cancer Date: 2008-08-23 Impact factor: 5.705

Review 10. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis.

Authors: Hesborn Wao; Rahul Mhaskar; Ambuj Kumar; Branko Miladinovic; Benjamin Djulbegovic
Journal: Syst Rev Date: 2013-02-04

41 in total

Recommendations on screening for lung cancer.

1. Conceptualizing overdiagnosis in cancer screening.

2. Introduction: Diagnosis and management of lung cancer: ACCP evidence-based clinical practice guidelines (2nd Edition).

3. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada.

4. Cost-effectiveness of CT screening in the National Lung Screening Trial.

5. Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization.

Review 6. Screening for lung cancer.

7. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).

8. Cost-effectiveness of Lung Cancer Screening in Canada.

9. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

Review 10. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis.

1. Cancer screening in Canada: What's in, what's out, what's coming.

Review 2. Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.

3. Controlled settings for lung cancer screening: why do they matter? Considerations for referring clinicians.

4. Practice organization for preventive screening.

5.

Review 6. The narrow path to organized LDCT lung cancer screening programs in Europe.

7. The OncoSim model: development and use for better decision-making in Canadian cancer control.

8. Autofluorescence bronchoscopy for lung cancer screening: a time to reflect.

9. Better decision making in preventive health screening: Balancing benefits and harms.

Review 10. Quality assurance and quantitative imaging biomarkers in low-dose CT lung cancer screening.